bpc-157 for gastological issues ORAL BPC-157 Delayed - 250mcg -
Description
To you who are reading this, do yourself a favor and check out this miracle for yourself
PubMed McGuire F, Hughes E, Maak T, Cushman DM Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review
The animal study was approved by Ethical Committees of the Instituto de Biologa y Medicina Experimental, Buenos Aires #24/2021
1 The KESIMPTA Phase 2 trial determined that once monthly frequency in a low SC dose was comparably effective, with fewer side effects, vs higher SC doses
Mild nausea Temporary dizziness Discomfort at the injury site (rare) This product is sold for research purposes only in compliance with Australian regulations
